FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a drug for external use. Medicinal preparation for external use contains products obtained by incubating the zooglea of the tea fungus. According to the invention, the preparation comprises the biomass of the zooglea of the tea fungus and a binder selected from the group: fish glue, casein glue, bone glue, albumin, carboxymethylcellulose, corn starch and/or dextrin, potato starch and/or dextrin, rice starch and/or dextrin, amylopectin starch and/or dextrin, high amylose starch and/or dextrin, barley starch and/or dextrin, wheat starch, pea starch and/or dextrin, flour paste, gelatin, gum rosin, resin damary, resin sandarac, resin of mastic wood, shellac, amber resin, copal, plum glue (resin), cherry glue (resin), gum arabic in the ratio: biomass of zooglea of tea fungus 3–70 % by weight, binder – the rest.
EFFECT: above-described preparation is effective for external application.
30 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COSMETIC AND / OR HEALTHFUL BIOLOGICALLY ACTIVE PREPARATION | 2017 |
|
RU2646468C1 |
| BIOLOGICALLY ACTIVE BIOMATERIAL PRODUCTION METHOD AND BIOMATERIAL PRODUCED BY SAID METHOD | 2012 |
|
RU2500198C1 |
| PREPARATION METHOD OF THE COMPLEX GEL FOR MASTITIS TREATMENT AND PREVENTION IN COWS AND COMPLEX GEL ON ITS BASIS | 2015 |
|
RU2624868C2 |
| WOUND-HEALING, ANTI-INFLAMMATORY OINTMENT ON THE BASIS OF TEA FUNGUS (MEDUSOMYCES GISEVII LINDAU) | 2017 |
|
RU2647458C1 |
| METHOD OF OBTAINING BIOLOGICALLY ACTIVE SUBSTANCE WITH PREBIOTIC EFFECT BASED ON MEDUSOMYCES GYSEVII | 2016 |
|
RU2630457C1 |
| DIET COMPOSITION WITH TREATMENT AND PREVENTIVE PROPERTIES | 2016 |
|
RU2626678C1 |
| RECOMBINANT ANGIOGENIN IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | 2022 |
|
RU2805144C1 |
| RECOMBINANT ANGIOGENIN IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | 2021 |
|
RU2784355C1 |
| METHOD FOR PRODUCTION OF BIODEGRADABLE COATING BASE | 2015 |
|
RU2641276C2 |
| METHOD FOR PRODUCING AN EMULSION CONTAINING NANO- AND MICROENCAPSULATED BIOLOGICALLY ACTIVE SUBSTANCES | 2020 |
|
RU2763171C1 |
